C07C 237/32
Having the nitrogen atom of the carboxamide group bound to an acyclic
Official title: having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by oxygen atoms
C07C237/32 (Having the nitrogen atom of the carboxamide group bound to an acyclic) appears on 106 US grants and 96 published applications in this corpus.
Search patents in C07C- Granted patents
- 106
- Published applications
- 96
- Assignees
- 78
- Inventors
- 328
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 2 |
| 2003 | 3 | 4 |
| 2004 | 2 | 5 |
| 2005 | 1 | 2 |
| 2006 | 5 | 6 |
| 2007 | 4 | 3 |
| 2008 | 4 | 16 |
| 2009 | 5 | 4 |
| 2010 | 3 | 8 |
| 2011 | 8 | 7 |
| 2012 | 4 | 0 |
| 2013 | 3 | 4 |
| 2014 | 8 | 3 |
| 2015 | 3 | 4 |
| 2016 | 4 | 5 |
| 2017 | 3 | 6 |
| 2018 | 5 | 4 |
| 2019 | 3 | 1 |
| 2020 | 3 | 3 |
| 2021 | 1 | 0 |
| 2022 | 3 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acid-binding photoprobes and uses thereof23 Dec 2025US 12,503,455 B2Arrakis Therapeutics, Inc.
- Nucleic acid-binding photoprobes and uses thereof7 Nov 2023US 11,807,623 B2Arrakis Therapeutics, Inc.
- Anthranilic amides and the use thereof11 Oct 2022US 11,465,978 B2Duquesne University of the Holy Ghost
- PPAR agonists23 Aug 2022US 11,420,934 B2Mitobridge, Inc.
- K-Ras modulators14 Jun 2022US 11,358,940 B2Leidos Biomedical Research, Inc.
- Protease inhibitors for treating or preventing coronavirus infection23 Jul 2026US 2026/0209180 A1Merck Sharp & Dohme Corp.
- Amido-Amine Hardener29 Jan 2026US 2026/0028451 A1
- Methods and compositions for inhibition of tyrosine and phenylalanine-mediated dna damage and repair22 Jan 2026US 2026/0021068 A1Functional Longevity Labs
- Process for the preparation of 2,4,6-triiodoisophthalic bisamides13 Feb 2025US 2025/0051267 A1Bracco Imaging S.P.A.
- Novel amino acid derivatives5 Dec 2024US 2024/0400499 A1PeptiDream Inc.
Most cited
By later US patents
- 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors87US 6,310,060 B1Warner-Lambert Company · 2001
- Anthranilic acid derivatives78US 5,716,993 AEisai Co., Ltd. · 1998
- Isoxazoline-substituted benzamide compound and pesticide68US 7,951,828 B1Nissan Chemical Industries, Ltd. · 2011
- Derivatization of non-natural amino acids and polypeptides61US 7,385,028 B2Ambrx, Inc. · 2008
- Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides60US 7,332,571 B2Ambrx, Inc. · 2008